Holen Sie sich die Stockscreener-App
0.00
100.00%
-179.95
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$179.95
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$9.42B
Einnahmen:
$1.56B
Nettoeinkommen (Verlust:
$216.80M
KGV:
0.00
EPS:
1.458
Netto-Cashflow:
$206.10M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$179.99
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
0.00 | 9.42B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
90.53 | 157.69B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
310.00 | 118.84B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.63 | 103.21B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.60 | 67.78B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.95 | 50.07B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Danaher achieves FDA clearance for Masimo feature, shares steady on NYSE - AD HOC NEWS
Deals tracker: Hackensack Meridian Health explores merger - Modern Healthcare
The Radius VSM from Masimo Corp.FDA-cleared opioid risk alerts on the wrist - AD HOC NEWS
California Forum Selection Clause Enforced in Lawsuit - The National Law Review
Danaher Finalizes $9.9B Purchase of Masimo - Orange County Business Journal
Masimo wins FDA clearance for wearable opioid-risk monitor - Stock Titan
Medtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires Masimo - Today's Medical Developments
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple - Stocktwits
Danaher boosts product portfolio with the acquisition of Masimo - MSN
SIRI stock surges 5% after-hours on S&P MidCap 400 inclusion - MSN
ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review - Law360
Masimo Corp (MASI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Masimo Corp (MASI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Masimo Corp (MASI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Masimo Corp (MASI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Katie Szyman Steps Down from Masimo - Orange County Business Journal
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Silent monitoring boost, Masimo Stork smart baby monitor targets anxious new parents - AD HOC NEWS
Masimo Corp. (Sound United): Denon AVR-X3800H stays a flexible 9.4-channel AV receiver - AD HOC NEWS
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com - Investing.com Nigeria
Danaher Deepens Diagnostics Reach As Masimo Deal Reshapes Healthcare Focus - Yahoo Finance
Masimo (MASI) director’s shares and RSUs cashed out at $180 in Danaher merger - Stock Titan
Masimo (MASI) director’s shares and RSUs cashed out in Danaher merger - Stock Titan
Masimo (MASI) director equity cashed out at $180 per share in Danaher merger - Stock Titan
[Form 4] MASIMO CORP Insider Trading Activity - Stock Titan
Politan Capital and Quentin Koffey cash out Masimo (MASI) at $180 per share - Stock Titan
Masimo (MASI) executive reports stock and RSU disposition in Danaher merger - Stock Titan
Masimo (MASI) EVP equity cashed out and converted in Danaher merger - Stock Titan
Masimo (MASI) CCO reports merger-driven cancellation and conversion of equity awards - Stock Titan
Masimo (MASI) CHRO equity canceled, cashed out and rolled into Danaher - Stock Titan
Masimo (MASI) GC reports RSU disposals as Danaher merger converts awards - Stock Titan
Masimo (MASI) CMO disposes RSUs, options as Danaher merger closes - Stock Titan
Masimo (MASI) CFO exits company stock as Danaher cash merger closes - Stock Titan
Masimo (MASI) CEO awards canceled, paid $180 per share in Danaher deal - Stock Titan
Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView
MASI Should I Buy - Intellectia AI
Masimo (MASI) bought out for $180 per share as Politan exits stake - Stock Titan
Danaher completes $10B acquisition of Masimo - MassDevice
Danaher Closes on Acquisition of Masimo - Orange County Business Journal
Masimo (MASI) removes unsold S-3 securities after Danaher merger - Stock Titan
Danaher completes acquisition of Masimo, company delists from Nasdaq - Investing.com UK
Masimo Pays Off and Terminates 2025 Credit Agreement as Danaher Merger Closes - TradingView
Danaher acquires Masimo (MASI) in all-cash $180-per-share takeover and delisting - Stock Titan
Masimo Corp (NASDAQ: MASI) common stock removed from Nasdaq listing - Stock Titan
Danaher completes acquisition of Masimo Corporation - Investing.com
Danaher completes acquisition of Masimo Corporation By Investing.com - Investing.com Canada
Danaher Completes Acquisition of Masimo Corporation - Yahoo Finance
Masimo Received Notice of Delisting - TradingView
MASI News | MASIMO CORP (NASDAQ:MASI) - ChartMill
Why is Sirius XM stock rallying today? By Investing.com - Investing.com India
Masimo Corporation stock hits 52-week high at 179.98 USD By Investing.com - Investing.com India
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.55%
1.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):